Test Bank
Abrams' Clinical Drug Therapy:
Rationales For Nursing Practice
By Frandsen And Pennington
13th edition
, Test bank for abrams’ clinical drug therapy rationales for nursing practice 13th edition
geralyn frandsen - isbn/issn 9781975136130
Table of content
Section 1 the conceptual framework of pharmacology chapter 1 the
foundation of pharmacology: quality and safety chapter 2 basic
concepts and processes
Chapter 3 medication administration and the nursing process of drug therapy
Section 2 drug therapy throughout the lifespan
Chapter 4 pharmacology and the care of infants and pediatric patients medication administration in
pediatrics
Chapter 5 pharmacology and the care of adults and geriatric patients
chapter 6 pharmacology and the care of pregnant or lactating woman
chapter 7 pharmacology and women’s health
Chapter 8 pharmacology and men’s health
Section 3 drugs affecting the hematopoietic and immune systems
Chapter 9 drug therapy for coagulation disorders
chapter 10 drug therapy for dyslipidemia
Chapter 11 drug therapy for hematopoietic disorders
chapter 12 drug therapy: immunizations
Chapter 13 drug therapy to decrease immunity chapter
14 drug therapy for the treatment of cancer
,Section 4 drugs affecting inflammation and infection
Chapter 15 inflammation, infection, and the use of antimicrobial agents
chapter 16 drug therapy to decrease pain, fever, and inflammation chapter
17 drug therapy with corticosteroids
Chapter 18 drug therapy with beta-lactam antibacterial agents chapter 19
drug therapy with aminoglycosides and fluoroquinolones
Chapter 20 drug therapy with tetracyclines, sulfonamides, and urinary antiseptics chapter
21 drug therapy with macrolides and miscellaneous anti-infective agents chapter 22 drug
therapy for tuberculosis and mycobacterium avium complex disease chapter 23 drug
therapy for viral infections
Chapter 24 drug therapy for fungal infections chapter
25 drug therapy for parasitic infections
Section 5 drugs affecting the cardiovascular system
Chapter 26 drug therapy for hypertension
chapter 27 drug therapy for dysrhythmias
Chapter 28 drug therapy for coronary heart disease
chapter 29 drug therapy for shock and hypotension
chapter 30 drug therapy for heart failure
Section 6 drugs affecting the respiratory system
Chapter 31 drug therapy for nasal congestion and cough
Chapter 32 drug therapy to decrease histamine effects and allergic response
chapter 33 drug therapy for asthma and bronchoconstriction
, Section 7 drugs affecting the renal and digestive systems
Chapter 34 drug therapy for fluid volume excess
Chapter 35 nutritional support products, vitamins, and mineral supplements
chapter 36 drug therapy for weight management
Chapter 37 drug therapy for peptic ulcer disease and hyperacidity
chapter 38 drug therapy for nausea and vomiting
Chapter 39 drug therapy for constipation and elimination problems
chapter 40 drug therapy for diarrhea
Section 8 drugs affecting the endocrine system
Chapter 41 drug therapy for diabetes mellitus
Chapter 42 drug therapy for hyperthyroidism and hypothyroidism chapter
43 drug therapy for pituitary and hypothalamic dysfunction chapter 44
drug therapy to regulate calcium and bone metabolism chapter 45 drug
therapy for addison’s disease and cushing’s disease
Section 9 drugs affecting the autonomic and central nervous system
Chapter 46 physiology of the autonomic and central nervous systems and indications for the use of drug
therapy
Chapter 47 drug therapy for myasthenia gravis, alzheimer’s disease, and urinary retention
Chapter 48 drug therapy for parkinson’s disease, urinary spasticity, and disorders requiring
anticholinergic drug therapy
Chapter 49 drug therapy with opioids
Chapter 50 drug therapy with local anesthetics
Abrams' Clinical Drug Therapy:
Rationales For Nursing Practice
By Frandsen And Pennington
13th edition
, Test bank for abrams’ clinical drug therapy rationales for nursing practice 13th edition
geralyn frandsen - isbn/issn 9781975136130
Table of content
Section 1 the conceptual framework of pharmacology chapter 1 the
foundation of pharmacology: quality and safety chapter 2 basic
concepts and processes
Chapter 3 medication administration and the nursing process of drug therapy
Section 2 drug therapy throughout the lifespan
Chapter 4 pharmacology and the care of infants and pediatric patients medication administration in
pediatrics
Chapter 5 pharmacology and the care of adults and geriatric patients
chapter 6 pharmacology and the care of pregnant or lactating woman
chapter 7 pharmacology and women’s health
Chapter 8 pharmacology and men’s health
Section 3 drugs affecting the hematopoietic and immune systems
Chapter 9 drug therapy for coagulation disorders
chapter 10 drug therapy for dyslipidemia
Chapter 11 drug therapy for hematopoietic disorders
chapter 12 drug therapy: immunizations
Chapter 13 drug therapy to decrease immunity chapter
14 drug therapy for the treatment of cancer
,Section 4 drugs affecting inflammation and infection
Chapter 15 inflammation, infection, and the use of antimicrobial agents
chapter 16 drug therapy to decrease pain, fever, and inflammation chapter
17 drug therapy with corticosteroids
Chapter 18 drug therapy with beta-lactam antibacterial agents chapter 19
drug therapy with aminoglycosides and fluoroquinolones
Chapter 20 drug therapy with tetracyclines, sulfonamides, and urinary antiseptics chapter
21 drug therapy with macrolides and miscellaneous anti-infective agents chapter 22 drug
therapy for tuberculosis and mycobacterium avium complex disease chapter 23 drug
therapy for viral infections
Chapter 24 drug therapy for fungal infections chapter
25 drug therapy for parasitic infections
Section 5 drugs affecting the cardiovascular system
Chapter 26 drug therapy for hypertension
chapter 27 drug therapy for dysrhythmias
Chapter 28 drug therapy for coronary heart disease
chapter 29 drug therapy for shock and hypotension
chapter 30 drug therapy for heart failure
Section 6 drugs affecting the respiratory system
Chapter 31 drug therapy for nasal congestion and cough
Chapter 32 drug therapy to decrease histamine effects and allergic response
chapter 33 drug therapy for asthma and bronchoconstriction
, Section 7 drugs affecting the renal and digestive systems
Chapter 34 drug therapy for fluid volume excess
Chapter 35 nutritional support products, vitamins, and mineral supplements
chapter 36 drug therapy for weight management
Chapter 37 drug therapy for peptic ulcer disease and hyperacidity
chapter 38 drug therapy for nausea and vomiting
Chapter 39 drug therapy for constipation and elimination problems
chapter 40 drug therapy for diarrhea
Section 8 drugs affecting the endocrine system
Chapter 41 drug therapy for diabetes mellitus
Chapter 42 drug therapy for hyperthyroidism and hypothyroidism chapter
43 drug therapy for pituitary and hypothalamic dysfunction chapter 44
drug therapy to regulate calcium and bone metabolism chapter 45 drug
therapy for addison’s disease and cushing’s disease
Section 9 drugs affecting the autonomic and central nervous system
Chapter 46 physiology of the autonomic and central nervous systems and indications for the use of drug
therapy
Chapter 47 drug therapy for myasthenia gravis, alzheimer’s disease, and urinary retention
Chapter 48 drug therapy for parkinson’s disease, urinary spasticity, and disorders requiring
anticholinergic drug therapy
Chapter 49 drug therapy with opioids
Chapter 50 drug therapy with local anesthetics
